The Impact of Tumour Size on the Probability of Synchronous Metastasis and Survival in Renal Cell Carcinoma Patients: a Population-based Study

Overview

Journal BMC Urol

Publisher Biomed Central

Specialty Urology

Date 2014 Sep 2

PMID 25174263

Citations 10

Authors

Johann P Ingimarsson

Martin I Sigurdsson

Sverrir Hardarson

Vigdis Petursdottir

Eirikur Jonsson

Gudmundur V Einarsson

Tomas Gudbjartsson

Affiliations

Soon will be listed here.

Abstract

Background: The observed low metastatic potential and favorable survival of small incidentally detected renal cell carcinomas (RCCs) have been a part of the rationale for recommending partial nephrectomy as a first treatment option and active surveillance in selected patients. We examined the relationship between tumor size and the odds of synchronous metastases (SMs) (primary outcome) and disease specific survival (secondary outcome) in a nationwide RCC registry.

Methods: Retrospective study of the 794 RCC patients diagnosed in Iceland between 1971 and 2005. Histological material and TNM staging were reviewed centrally. The presence of SM and survival were recorded. Cubic spline analysis was used to assess relationship between tumor size and probability of SM. Univariate and multivariate statistics were used to estimate prognostic factors for SM and survival.

Results: The probability of SM increased in a non-linear fashion with increasing tumor size (11, 25, 35, and 50%) for patients with tumors of ≤4, 4.1-7.0, 7.1-10.0, and >10 cm, respectively. On multivariate analysis, tumor size was an independent prognostic factor for disease-specific survival (HR = 1.05, 95% CI 1.02-1.09, p < 0.001), but not for SM.

Conclusion: Tumor size affected the probability of disease-specific mortality but not SM, after correcting for TNM staging in multivariate analysis. This confirms the prognostic ability of the 2010 TNM staging system for renal cell cancer in the Icelandic population.

Citing Articles

Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinoma.

Jespersen J, Lindgaard C, Iisager L, Ahrenfeldt J, Lyskjaer I Nat Rev Urol. 2025; .

PMID: 39789293 DOI: 10.1038/s41585-024-00980-x.

Characteristics, aetiology and implications for management of multiple primary renal tumours: a systematic review.

Zhang H, Andreou A, Bhatt R, Whitworth J, Yngvadottir B, Maher E Eur J Hum Genet. 2024; 32(8):887-894.

PMID: 38802529 PMC: 11291654. DOI: 10.1038/s41431-024-01628-5.

Small renal mass with large lymph nodal metastasis and inferior vena cava thrombus: an exceptional amalgamation.

Akif S, Parmar K, Kumar S, Mavuduru R, Bal A Ann R Coll Surg Engl. 2022; 104(6):e183-e186.

PMID: 35175141 PMC: 9157785. DOI: 10.1308/rcsann.2021.0303.

Prolonged natural history of a cystic renal cell carcinoma: A case report.

Gupta M, Kaundal P, Bora G, Gorsi U, Mavuduru R Indian J Urol. 2020; 36(4):315-317.

PMID: 33376271 PMC: 7759162. DOI: 10.4103/iju.IJU_177_20.

Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers.

Park J, Pierorazio P, Lee J, Lee H, Lim Y, Jang W Cancers (Basel). 2020; 12(1).

PMID: 31963294 PMC: 7017065. DOI: 10.3390/cancers12010222.

References

Gudmundsson E, Hellborg H, Lundstam S, Erikson S, Ljungberg B . Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data. Eur Urol. 2011; 60(5):975-82. DOI: 10.1016/j.eururo.2011.06.029. View

Pahernik S, Ziegler S, Roos F, Melchior S, Thuroff J . Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol. 2007; 178(2):414-7. DOI: 10.1016/j.juro.2007.03.129. View

Yoo C, Song C, Hong J, Kim C, Ahn H . Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. J Urol. 2008; 180(2):486-91. DOI: 10.1016/j.juro.2008.04.034. View

Campbell S, Novick A, Belldegrun A, Blute M, Chow G, Derweesh I . Guideline for management of the clinical T1 renal mass. J Urol. 2009; 182(4):1271-9. DOI: 10.1016/j.juro.2009.07.004. View

Ljungberg B, Cowan N, Hanbury D, Hora M, Kuczyk M, Merseburger A . EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010; 58(3):398-406. DOI: 10.1016/j.eururo.2010.06.032. View

Kume H, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Nishimatsu H . Distant metastasis of renal cell carcinoma with a diameter of 3 cm or less-which is aggressive cancer?. J Urol. 2010; 184(1):64-8. DOI: 10.1016/j.juro.2010.03.019. View

Gudbjartsson T, Thoroddsen A, Petursdottir V, Hardarson S, Magnusson J, Einarsson G . Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology. 2005; 66(6):1186-91. DOI: 10.1016/j.urology.2005.07.009. View

Cheville J, Blute M, Zincke H, Lohse C, Weaver A . Stage pT1 conventional (clear cell) renal cell carcinmoa: pathological features associated with cancer specific survival. J Urol. 2001; 166(2):453-6. DOI: 10.1016/s0022-5347(05)65962-9. View

Karakiewicz P, Lewinshtein D, Chun F, Briganti A, Guille F, Perrotte P . Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol. 2006; 50(3):521-8. DOI: 10.1016/j.eururo.2006.02.034. View

10.

Schips L, Lipsky K, Zigeuner R, Salfellner M, Winkler S, Langner C . Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients. Urology. 2003; 62(6):1024-8. DOI: 10.1016/s0090-4295(03)00763-5. View

11.

Klatte T, Patard J, de Martino M, Bensalah K, Verhoest G, De La Taille A . Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol. 2008; 179(5):1719-26. DOI: 10.1016/j.juro.2008.01.018. View

12.

Lughezzani G, Jeldres C, Isbarn H, Perrotte P, Shariat S, Sun M . Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis. J Urol. 2009; 182(4):1287-93. DOI: 10.1016/j.juro.2009.06.018. View

13.

Kates M, Korets R, Sadeghi N, Pierorazio P, McKiernan J . Predictors of locally advanced and metastatic disease in patients with small renal masses. BJU Int. 2011; 109(10):1463-7. DOI: 10.1111/j.1464-410X.2011.10553.x. View

14.

Klatte T, Patard J, Goel R, Kleid M, Guille F, Lobel B . Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience. J Urol. 2007; 178(1):35-40. DOI: 10.1016/j.juro.2007.03.046. View

15.

Thompson R, Hill J, Babayev Y, Cronin A, Kaag M, Kundu S . Metastatic renal cell carcinoma risk according to tumor size. J Urol. 2009; 182(1):41-5. PMC: 2735023. DOI: 10.1016/j.juro.2009.02.128. View

16.

Brookman-May S, May M, Zigeuner R, Shariat S, Scherr D, Chromecki T . Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma. J Urol. 2011; 186(6):2175-81. DOI: 10.1016/j.juro.2011.07.105. View

17.

Ficarra V, Prayer-Galetti T, Novara G, Bratti E, Zanolla L, Bianco M . Tumor-size breakpoint for prognostic stratification of localized renal cell carcinoma. Urology. 2004; 63(2):235-9. DOI: 10.1016/j.urology.2003.09.081. View

18.

Waalkes S, Becker F, Schrader A, Janssen M, Wegener G, Merseburger A . Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?. Eur Urol. 2010; 59(2):258-63. DOI: 10.1016/j.eururo.2010.10.005. View

19.

Nguyen M, Gill I . Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality. J Urol. 2009; 181(3):1020-7. DOI: 10.1016/j.juro.2008.11.023. View

20.

Hutterer G, Patard J, Jeldres C, Perrotte P, De La Taille A, Salomon L . Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram. BJU Int. 2007; 101(1):39-43. DOI: 10.1111/j.1464-410X.2007.07170.x. View